Distinct Clinical Phenotypes of Patients with Myeloid Neoplasms Carrying SF3B1 Hotspot Mutations
Jack Khouri(Cleveland Clinic), Hetty E. Carraway(Cleveland Clinic), Valeria Visconte(Cleveland Clinic), Elise LeMelle(Cleveland Clinic), Jennifer S. Carew(University of Arizona), Bartlomiej Przychodzen(Cleveland Clinic), Aaron T. Gerds(Cleveland Clinic), Yogenthiran Saunthararajah(Cleveland Clinic), Mikkael A. Sekeres(University of Miami), Teodora Kuzmanovic(Cleveland Clinic), Steffan T. Nawrocki(University of Arizona), Heesun J. Rogers(Cleveland Clinic), Vera Ademà(Cleveland Clinic), Françesc Solé(Fundación Josep Carreras Contra la Leucemia), Anjali S. Advani(Cleveland Clinic), Jaroslaw P. Maciejewski(Cleveland Clinic), Aziz Nazha, Ying Ni(Beijing Normal University), Yazan F. Madanat(The University of Texas Southwestern Medical Center), Sudipto Mukherjee(Cleveland Clinic), Cassandra M. Hirsch(Cleveland Clinic), Matt Kalaycio(Georgetown University), Bhumika J. Patel(Cleveland Clinic)
Cited by 0
Related Papers
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k
United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic Leukemia
|Journal of Clinical Oncology|2001|825